A Study of application of Jalauka(Medicinal Leech) with and without Vamana Karma(Therapeutic Emesis) in the Management of Mandal Kushtha(Psoriasis).

â??An Open Randomized Comparative Clinical Study of Vamanottara Jalaukavacharana and Jalaukavacharana in the Management of Mandal Kushtha w.s.r. to Psoriasisâ??

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015534

Enrollment

Registered

2018-08-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L40-L45- Papulosquamous disorders Health Condition 2: L409- Psoriasis, unspecified

Interventions

Intervention1: Group A: Vamana Karma followed by Jalaukavacharana will be done in 15 patients. . Vamana procedure 1. Deepana, Pachana with Panchakol Choorna (3 gm) twice a day before food till appear

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients between 18 to 60 years of age. b) Patients with the classical features of Mandal Kushtha (psoriasis). c) Patients not taking any other medicine for Mandal Kushtha (psoriasis). d) Patients fit for Vamana and Jalaukavacharana. e) Patients willing to sign consent form for trial.

Exclusion criteria

Exclusion criteria: 1. Pregnant women and lactating mothers. 2. Patients suffering from systemic disorders as Cardiac Problem, Uncontrolled Diabetes mellitus, Uncontrolled Hypertension, Paralysis, Malignancy, HIV, HBsAg, Leprosy. 3. Patients unfit for Vamana karma and Jalaukavacharana.

Design outcomes

Primary

Measure	Time frame
Assessment of changes in specific signs and symptoms of Mandal Kushtha (psoriasis).Timepoint: 60 days	—

Secondary

Measure	Time frame
A Any adverse effect in the values of hematological test and in clinical signs and symptoms.Timepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Pravesh Srivastava

National Institute of Ayurveda

gmangal108@gmail.com8619849011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026